Expression of cancer testis antigens NY-ESO-1, MAGE-A1 and MAGE-A4 as a prognostic factor in patients with primary cutaneous melanoma

被引：0
|
作者：
Katalinic, D. [1 ]
机构：
[1] Univ Hosp Ctr Zagreb, Zagreb, Croatia
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2014年 / 171卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
079
引用
收藏
页码：E48 / E48
页数：1
相关论文
共 50 条
  • [1] Expression of cancer testis antigens NY-ESO-1, MAGE-A1 and MAGE-A4 as a prognostic factor in patients with primary cutaneous melanoma
    Katalinic, D.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 : 36 - 36
  • [2] Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma
    Errington, J. A.
    Conway, R. M.
    Walsh-Conway, N.
    Browning, J.
    Freyer, C.
    Cebon, J.
    Madigan, M. C.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2012, 96 (03) : 451 - 458
  • [3] Expression of MAGE-A1, MAGE-A3/4 and NY-ESO-1 Cancer-Testis Antigens in Fetal Testis
    Hudolin, Tvrtko
    Kastelan, Zeljko
    Derezic, Danijel
    Basic-Jukic, Nikolina
    Spagnoli, Giulio Cesare
    Juretic, Antonio
    Jezek, Davor
    ACTA DERMATOVENEROLOGICA CROATICA, 2009, 17 (02) : 103 - 107
  • [4] Clinicopathological assessment of cancer/testis antigens NY-ESO-1 and MAGE-A4 in osteosarcoma
    Hashimoto, Kazuhiko
    Nishimura, Shunji
    Ito, Tomohiko
    Oka, Naohiro
    Kakinoki, Ryosuke
    Akagi, Masao
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2022, 66 (03):
  • [5] Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms
    Yakirevich, E
    Sabo, E
    Lavie, O
    Mazareb, S
    Spagnoli, GC
    Resnick, MB
    CLINICAL CANCER RESEARCH, 2003, 9 (17) : 6453 - 6460
  • [6] Protein expression of cancer testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT7 and NY-ESO-1 in low stage epithelial ovarian tumors
    不详
    PATHOLOGY RESEARCH AND PRACTICE, 2005, 201 (03) : 178 - 178
  • [7] Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients
    Sandra N. Freiberger
    David Holzmann
    Grégoire B. Morand
    Martin Hüllner
    Mitchell P. Levesque
    Reinhard Dummer
    Viktor H. Koelzer
    Niels J. Rupp
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5645 - 5653
  • [8] Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients
    Freiberger, Sandra N.
    Holzmann, David
    Morand, Gregoire B.
    Huellner, Martin
    Levesque, Mitchell P.
    Dummer, Reinhard
    Koelzer, Viktor H.
    Rupp, Niels J.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (09) : 5645 - 5653
  • [9] Should we consider cancer/testis antigens NY-ESO-1, MAGE-A4 and MAGE-A1 as potential targets for immunotherapy in vulvar squamous cell carcinoma?
    Sznurkowski, Jacek J.
    Zawrocki, Anton
    Karczewska, Joanna
    Emerich, Janusz
    Biernat, Wojciech
    HISTOPATHOLOGY, 2011, 58 (03) : 481 - 483
  • [10] Expression of Cancer-Testis Antigens MAGE-A1, MAGE-A4, NY-ESO-1 and PRAME in Bone and Soft Tissue Sarcomas: The Experience From a Single Center in China
    Chen, Anni
    Qiu, Yuling
    Yen, Ying-Tzu
    Wang, Chun
    Wang, Xiaolu
    Li, Chunhua
    Wei, Zijian
    Li, Lin
    Yu, Lixia
    Liu, Fangcen
    Li, Rutian
    CANCER MEDICINE, 2025, 14 (07):
12345